Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Quetiapine mitigates the neuroinflammation and oligodendrocyte loss in the brain of C57BL/6 mouse following cuprizone exposure for one week.
Validation of Social Media Analysis for Outcomes Research: Identification of Drivers of Switches between oral and Injectable Therapies for Multiple Sclerosis.
Motor unit number index (MUNIX): Is it relevant in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?
Improved Framework for Tractography Reconstruction of the Optic Radiation.
Deciphering Depressive Mood in Relapsing-Remitting and Progressive Multiple Sclerosis and Its Consequence on Quality of Life.
Home or away? Choosing a setting for a falls-prevention program for people with multiple sclerosis.
Repeatability of quantitative sodium magnetic resonance imaging for estimating pseudo-intracellular sodium concentration and pseudo-extracellular volume fraction in brain at 3 T.
Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy.
Ninjurin1 deficiency attenuates susceptibility of experimental autoimmune encephalomyelitis in mice.
Attributions and self-efficacy for physical activity in multiple sclerosis.
False positivity of anti aquaporin-4 antibodies in natalizumab-treated patients.
Erratum to: 'Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial'.
Improved neurite outgrowth on central nervous system myelin substrate by siRNA-mediated knockdown of Nogo receptor.
Use of complementary and alternative medicine in patients with cancer or multiple sclerosis: possible public health implications.
Enzyme activity assays for protein kinases: Strategies to identify active substrates.
Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction.
Multiparity in women with multiple sclerosis causes less long-term disability: Commentary.
The impact of microglial activation on blood-brain barrier in brain diseases.
Laquinimod therapy in multiple sclerosis: a comprehensive review.
Development of Quinoline-2,4(1H,3H)-diones as Potent and Selective ligands of the Cannabinoid Type 2 Receptor.
Comparing statistical methods for removing seasonal variation from vitamin D measurements in case-control studies.
The Effect of Plasma Exchange on the Expression of FOXP3 and RORC2 in Relapsed Multiple Sclerosis Patients.
Inducible Expression of CXCL1 within the Central Nervous System Amplifies Viral-Induced Demyelination.
Signaling through three chemokine receptors triggers the migration of transplanted neural precursor cells in a model of multiple sclerosis.
Pages
« first
‹ previous
…
685
686
687
688
689
690
691
692
693
…
next ›
last »